These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
702 related articles for article (PubMed ID: 21779943)
1. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943 [TBL] [Abstract][Full Text] [Related]
2. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481 [TBL] [Abstract][Full Text] [Related]
4. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients. Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388 [TBL] [Abstract][Full Text] [Related]
5. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044 [TBL] [Abstract][Full Text] [Related]
6. Glomerular and tubular damage markers are elevated in patients with diabetes. Nauta FL; Boertien WE; Bakker SJ; van Goor H; van Oeveren W; de Jong PE; Bilo H; Gansevoort RT Diabetes Care; 2011 Apr; 34(4):975-81. PubMed ID: 21307379 [TBL] [Abstract][Full Text] [Related]
7. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Bonventre JV; Sabbisetti V; Waikar SS; Mifflin TE; Zhang X; Xie D; Hsu CY; Feldman HI; Coresh J; Vasan RS; Kimmel PL; Liu KD; Diabetologia; 2015 Jan; 58(1):188-98. PubMed ID: 25316431 [TBL] [Abstract][Full Text] [Related]
8. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Nielsen SE; Schjoedt KJ; Astrup AS; Tarnow L; Lajer M; Hansen PR; Parving HH; Rossing P Diabet Med; 2010 Oct; 27(10):1144-50. PubMed ID: 20854382 [TBL] [Abstract][Full Text] [Related]
9. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Nielsen SE; Andersen S; Zdunek D; Hess G; Parving HH; Rossing P Kidney Int; 2011 May; 79(10):1113-8. PubMed ID: 21270761 [TBL] [Abstract][Full Text] [Related]
10. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388 [TBL] [Abstract][Full Text] [Related]
11. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131 [TBL] [Abstract][Full Text] [Related]
12. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study. Bhavsar NA; Köttgen A; Coresh J; Astor BC Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304 [TBL] [Abstract][Full Text] [Related]
13. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue? Pennemans V; Rigo JM; Faes C; Reynders C; Penders J; Swennen Q Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635 [TBL] [Abstract][Full Text] [Related]
14. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients. Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836 [TBL] [Abstract][Full Text] [Related]
15. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1? Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771 [TBL] [Abstract][Full Text] [Related]
16. Biomarkers for early detection of sickle nephropathy. Sundaram N; Bennett M; Wilhelm J; Kim MO; Atweh G; Devarajan P; Malik P Am J Hematol; 2011 Jul; 86(7):559-66. PubMed ID: 21630304 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of urinary tubule injury markers for predicting progression of renal dysfunction in patients with type 2 diabetes and albuminuria: The Fukuoka Diabetes Registry. Ide H; Iwase M; Ohkuma T; Fujii H; Komorita Y; Oku Y; Higashi T; Yoshinari M; Nakamura U; Kitazono T Diabetes Res Clin Pract; 2022 Apr; 186():109840. PubMed ID: 35331809 [TBL] [Abstract][Full Text] [Related]
18. Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients. Chou KM; Lee CC; Chen CH; Sun CY PLoS One; 2013; 8(1):e54863. PubMed ID: 23349979 [TBL] [Abstract][Full Text] [Related]
19. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. Vaidya VS; Niewczas MA; Ficociello LH; Johnson AC; Collings FB; Warram JH; Krolewski AS; Bonventre JV Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978 [TBL] [Abstract][Full Text] [Related]
20. Urinary Kidney Injury Molecules in Children with Iron-Deficiency Anemia. Güneş A; Ece A; Aktar F; Tan İ; Söker M; Karabel D; Balık H; Uluca Ü; Şen V; Yolbaş İ Med Sci Monit; 2015 Dec; 21():4023-9. PubMed ID: 26697893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]